Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 712 of 5804
-
New Gene-Based bladder cancer treatment shows promise in early trial
Disease control Recruiting nowThis study will evaluate the safety and efficacy of intravesical administration of detalimogene (EG-70) in the bladder and its effect on bladder tumors in patients with NMIBC. This study study consists of two phases; a Phase 1 dose-escalation to establish safety and recommended …
Phase: PHASE1, PHASE2 • Sponsor: enGene, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a 'Microbiome Transplant' stop recurring vaginal infections?
Disease control Recruiting nowThis is a randomized trial of vaginal microbiome transplant vs. saline placebo to restore a Lactobacillus dominant vaginal microbial community in women with recurrent bacterial vaginosis.
Phase: PHASE1, PHASE2 • Sponsor: Douglas Kwon • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Immune cells take on tough tumors in early trial
Disease control Recruiting nowThis is a single-center, single-arm phase I clinical trial.The study process was divided into: screening period, sampling and production period, NMA-LD chemotherapy , treatment and observation period, and follow-up period.
Phase: PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New combo therapy aims to boost immune response in hard-to-treat breast cancers
Disease control Recruiting nowThe purpose of this study is to find out whether adding pembrolizumab, with or without olaparib, to standard radiation therapy is a safe and effective treatment for metastatic breast cancer, , and to see whether the study treatment is better than, the same as, or worse than the u…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a common antibiotic boost chemo for tough breast cancer?
Disease control Recruiting nowThe primary objective of this study is to compare progression-free survival (PFS) of patients with metastatic triple-negative breast cancer randomised to treatment with standard chemotherapy plus moxifloxacin or placebo.
Phase: PHASE3 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for COVID-19 patients on ventilators: drug combo trial completed
Disease control CompletedThis study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure. Participants in the study will be treated with either a study drug plus current standard of car…
Phase: PHASE3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Cancer drug shows promise for lupus kidney disease
Disease control OngoingThe purpose of this research is to study the safety and efficacy of daratumumab in inducing complete or partial remission in patients with active lupus nephritis.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Targeted drug cobimetinib tested for rare immune cell cancers
Disease control Recruiting nowThis is a research study of a drug called cobimetinib in children and adults diagnosed with Langerhans cell histiocytosis (LCH), and other histiocytic disorders that has returned or does not respond to treatment. Cobimetinib blocks activation of a protein called Mitogen-activated…
Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control
Last updated Jun 26, 2026 17:51 UTC
-
Proton beams may ease brain tumor treatment side effects
Symptom relief Recruiting nowRadiation therapy is an integral part of the multimodal primary therapy of glioblastomas. As the overall prognosis in this tumor entity remains unfavorable, current research is focused on additional drug therapies, which are often accompanied by increases in toxicity. By using pr…
Phase: NA • Sponsor: University Hospital Heidelberg • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New program aims to keep teens off opioids with medication and support
Disease control Recruiting nowThe Houston Emergency Response Opioid Engagement System for Youths and Adolescents (Young HEROES) is a community-based research program integrating assertive outreach, medication for opioid use disorder (MOUD), behavioral counseling, and peer recovery support. The objective is to…
Phase: PHASE4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New combo attack: surgery and drugs take on tough liver cancer
Disease control OngoingThe treatment strategies for HCC with PVTT is still controversial, and differ substantially between the west and the east. According to western guidelines, including those of the EASL, BCLC, and AASLD, PVTT is regarded as a contra-indication to initial surgery or transarterial ch…
Phase: PHASE3 • Sponsor: Jia Fan • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a simple shot prevent brain bleeding after a fall?
Disease control Recruiting nowTranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and dementia in older adults with symptomatic mild head injury
Phase: PHASE3 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Heated chemo combo could tame stomach cancer spread
Disease control Recruiting nowThis is a Phase II treatment study analyzing the role of preoperative chemotherapy, preoperative laparoscopic HIPEC, and gastrectomy with CRS/HIPEC in gastric adenocarcinoma patients with cytology-positive only carcinomatosis, radiologically-occult carcinomatosis, or radiology ap…
Phase: PHASE2 • Sponsor: Banner Health • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New targeted therapy shows promise for Hard-to-Treat lung cancer
Disease control OngoingThis phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to …
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New surgery trial aims to restore vision after macular bleeding
Disease control Recruiting nowThe centre of the retina (macula) at the back of the eye contains cells that give us our central vision that we use for reading and recognising faces. These cells can be damaged by a disease called wet age-related macular degeneration (AMD), where new abnormal blood vessels grow …
Phase: PHASE3 • Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Teens with HIV get boost from phone apps and peer helpers in nigeria
Disease control CompletedCombination interventions with mHealth and Peer Navigation components will be evaluated in a randomized, stepped wedge trial among youth in Ibadan, Lagos, Sagamu, and Jos, Nigeria. Study findings will demonstrate whether or not the combination interventions for HIV treatment outc…
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a short drug course end malaria relapses for good?
⭐️ CURE ⭐️ CompletedThe study will be an open-labelled randomized clinical trial to determine therapeutic efficacy. Note that this will not be an Investigational New Drug application, as only World Health Organization (WHO)-approved drugs will be used at dosage and for conditions approved.
Phase: PHASE4 • Sponsor: University of Maryland, Baltimore • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 13:00 UTC
-
New hope for rare kidney disease: drug targets oxalate buildup in severe cases
Disease control Recruiting nowThe aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.
Phase: PHASE2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Blood test and AI could spot liver cancer early, saving lives
Knowledge-focused OngoingHepatocellular carcinoma (HCC) is the 7th most common cause of cancer death globally but only 20% are diagnosed in its early stages where cure is possible. Current standard-of-care surveillance of patients at high risk of developing HCC with 6-monthly serum alpha-fetoprotein (AFP…
Sponsor: National Cancer Centre, Singapore • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Custom-Made vaccine takes on liver cancer after surgery
Disease control Recruiting nowThis is a single arm phase II study of adjuvant intra-dermal NA DC vaccine combined with intravenous nivolumab in patients with resectable HCC (group A) or CRLM (group B) planned for curative surgery (with/without local ablation).
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC